Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Johnson & Johnson to test experimental HIV vaccine in U.S., Europe

Johnson & Johnson plans to conduct a late-stage study of the company’s investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.

Read More »

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

Teva Pharmaceutical agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that the world’s largest generic manufacturer and other drugmakers helped fuel the U.S. opioid epidemic.

Read More »

U.S. measles outbreak spreads to Maine, 25th state to report case

Maine became the 25th U.S. state to confirm a case of measles amid the country’s worst outbreak of the disease in a quarter century.

Read More »

Five U.S. states sue Purdue Pharma over marketing, selling of opioids

Five U.S. states filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, including OxyContin.

Read More »

Two Pharma Companies Expand on the Coasts, Open New Facilities

With the acquisition of Shire, Takeda Pharmaceutical is building up the company’s research and development presence in the United States. Additionally, Insulet Corporation is celebrating the grand opening of the company’s new global headquarters and U.S. manufacturing facility in Acton, Mass.

Read More »

As measles returns, U.S. states look to cut vaccine exemptions

Maine could soon prohibit parents from citing religious or personal beliefs to avoid vaccinating their children, making the U.S. state one of a half dozen cracking down during the nations’ largest measles outbreak in 25 years.

Read More »

McKesson to pay $37 million to resolve West Virginia opioid lawsuit

Drug distributor McKesson Corp. agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold the company responsible for contributing to the opioid epidemic, the state’s attorney general said.

Read More »

To Bolster Shingrix Production, GSK Invests $100 Million in Montana Manufacturing Facility

GlaxoSmithKline is investing heavily in a Montana manufacturing facility that specializes in the manufacture of the company’s two-year-old shingles vaccine Shingrix, which is eying blockbuster status.

Read More »

Kite Builds Maryland CAR-T Manufacturing Site That Could Employ up to 900

Gilead Sciences subsidiary Kite Pharma broke ground on a Maryland facility that will significantly expand the company’s ability to manufacture a variety of CAR-T therapies, including the company’s previously approved Yescarta.

Read More »

Swiss drugmaker Roche ups outlook as sales growth offsets price hit

Roche lifted the Swiss drugmaker’s 2019 outlook as sales growth in China and the United States outpaced price declines the company has suffered amid President Donald Trump’s pressure on the industry to hold down charges.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom